Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors-Reference-Cited by-同舟云学术

Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors

Published:2023-02 Issue: Volume:188 Page:106591
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Donniacuo M.,De Angelis A.,Telesca M.,Bellocchio G.,Riemma M.A.,Paolisso P.,Scisciola L.,Cianflone E.,Torella D.,Castaldo G.,Capuano A.,Urbanek K.,Berrino L.,Rossi F.,Cappetta D.

Publisher

Elsevier BV

Subject

Pharmacology

Reference146 articles.

1. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms;Andrade;Circ. Res.,2014

2. Atrial fibrillation;Brundel BJJM;Nat. Rev. Dis. Prim.,2022

3. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge;Lippi;Int. J. Stroke,2021

4. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights;Kornej;Circ. Res.,2020

5. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact;Dilaveris;Clin. Cardiol.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic Strategies;Biomolecules;2024-06-25

2. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects;Frontiers in Pharmacology;2024-06-14

3. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review;Biomedicine & Pharmacotherapy;2024-06

4. Correlation between Electrocardiogram Changes and Right Ventricular Systolic Function in Patients with Chronic Atrial Fibrillation;The Heart Surgery Forum;2024-05-19

5. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12